MEP12109A - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number
MEP12109A
MEP12109A MEP-121/09A MEP12109A MEP12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A ME P12109 A MEP12109 A ME P12109A
Authority
ME
Montenegro
Prior art keywords
improved properties
reconstituted surfactants
surfactants
relates
present
Prior art date
Application number
MEP-121/09A
Other languages
Bosnian (bs)
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP12109(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of MEP12109A publication Critical patent/MEP12109A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
MEP-121/09A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties MEP12109A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Publications (1)

Publication Number Publication Date
MEP12109A true MEP12109A (en) 2011-12-20

Family

ID=39079026

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-121/09A MEP12109A (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2016-20A ME02326B (me) 2006-10-13 2007-09-28 Rekonstituisani surfaktanti sa poboljšanim svojstvima

Country Status (35)

Country Link
US (2) US8183210B2 (https=)
EP (1) EP2078038B1 (https=)
JP (2) JP5405307B2 (https=)
KR (1) KR101328851B1 (https=)
CN (2) CN101522711B (https=)
AR (2) AR063263A1 (https=)
AU (1) AU2007306075B2 (https=)
BR (1) BRPI0715317B1 (https=)
CA (1) CA2666344C (https=)
CL (1) CL2007002931A1 (https=)
CO (1) CO6400235A2 (https=)
CY (1) CY1114716T1 (https=)
DK (1) DK2078038T3 (https=)
EA (1) EA015802B1 (https=)
ES (1) ES2438727T3 (https=)
GE (1) GEP20125531B (https=)
HR (1) HRP20140052T1 (https=)
IL (1) IL198075A (https=)
JO (1) JO2963B1 (https=)
MA (1) MA31062B1 (https=)
ME (2) MEP12109A (https=)
MX (1) MX343064B (https=)
MY (1) MY148127A (https=)
NO (1) NO342038B1 (https=)
NZ (1) NZ576189A (https=)
PE (1) PE20081184A1 (https=)
PL (1) PL2078038T3 (https=)
PT (1) PT2078038E (https=)
RS (1) RS53172B (https=)
SI (1) SI2078038T1 (https=)
TN (1) TN2009000099A1 (https=)
TW (1) TWI388333B (https=)
UA (1) UA94477C2 (https=)
WO (1) WO2008044109A1 (https=)
ZA (1) ZA200902481B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
US9815869B2 (en) 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
AR093569A1 (es) 2012-11-21 2015-06-10 Chiesi Farm Spa Tensioactivos pulmonares reconstituidos
US10717777B2 (en) 2015-12-17 2020-07-21 The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
RU2748417C2 (ru) 2016-08-24 2021-05-25 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Стабильная фармацевтическая композиция, включающая восстановленную композицию легочного сурфактанта
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties
EP4228691A4 (en) * 2020-10-16 2025-01-01 Biosuperior Technology, Inc. PULMONARY TREATMENT COMPOSITIONS
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001164A1 (en) * 1993-06-30 1995-01-12 Genentech, Inc. Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2658478C (en) * 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
EP2078038B1 (en) 2013-11-20
HK1134497A1 (en) 2010-04-30
CY1114716T1 (el) 2016-10-05
US20100004173A1 (en) 2010-01-07
CA2666344C (en) 2017-04-18
PE20081184A1 (es) 2008-09-26
MX343064B (es) 2016-10-24
AU2007306075B2 (en) 2012-08-09
DK2078038T3 (da) 2013-12-02
PL2078038T3 (pl) 2014-05-30
KR20090083892A (ko) 2009-08-04
PT2078038E (pt) 2013-12-12
CN101522711A (zh) 2009-09-02
GEP20125531B (en) 2012-05-25
BRPI0715317B1 (pt) 2021-10-05
AR113422A2 (es) 2020-04-29
ES2438727T3 (es) 2014-01-20
EA200900373A1 (ru) 2009-10-30
HRP20140052T1 (hr) 2014-02-28
US8183210B2 (en) 2012-05-22
AR063263A1 (es) 2009-01-14
NZ576189A (en) 2011-09-30
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
JP2013241449A (ja) 2013-12-05
JP5405307B2 (ja) 2014-02-05
CA2666344A1 (en) 2008-04-17
MX2009003638A (es) 2009-04-22
CN101522711B (zh) 2013-11-13
MA31062B1 (fr) 2010-01-04
CN103169947A (zh) 2013-06-26
HK1185274A1 (en) 2014-02-14
IL198075A0 (en) 2011-08-01
JP2010505937A (ja) 2010-02-25
KR101328851B1 (ko) 2013-11-14
JO2963B1 (en) 2016-03-15
WO2008044109A1 (en) 2008-04-17
ZA200902481B (en) 2010-07-28
TN2009000099A1 (en) 2010-08-19
NO20091441L (no) 2009-06-23
ME02326B (me) 2016-06-20
UA94477C2 (ru) 2011-05-10
AU2007306075A1 (en) 2008-04-17
RS53172B (sr) 2014-06-30
US9238058B2 (en) 2016-01-19
CL2007002931A1 (es) 2008-03-24
TW200824705A (en) 2008-06-16
TWI388333B (zh) 2013-03-11
EA015802B1 (ru) 2011-12-30
BRPI0715317A2 (pt) 2013-07-09
IL198075A (en) 2016-04-21
US20130079275A1 (en) 2013-03-28
NO342038B1 (no) 2018-03-19
MY148127A (en) 2013-02-28
EP2078038A1 (en) 2009-07-15
SI2078038T1 (sl) 2014-02-28

Similar Documents

Publication Publication Date Title
MEP12109A (en) Reconstituted surfactants having improved properties
ATE544461T1 (de) Rekonstituierte tenside mit verbesserten eigenschaften
BRPI1010120A2 (pt) composição de surfactante reconstituído melhorada contendo análogos de proteína b do surfactante (sp-b) e proteína c do surfactante ( sp-c)
EA201000399A1 (ru) Композиции и способы использования проостровковых пептидов и их аналогов
BRPI0813699A2 (pt) Formulações de proteína de fusão glp-1-fc
CR10405A (es) Formulaciones novedosas que establizan e inhiben la precipitacion de composiciones inmunogenicas
WO2006136607A3 (de) Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
MX340541B (es) Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
AR108631A1 (es) Formulación de neurotoxinas
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
PL1940381T3 (pl) Farmaceutyczne kompozycje do oczu oparte na aminokwasach i hialuronianie sodu
WO2013120058A3 (en) Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof
MX2022004944A (es) Composiciones y metodos para minimizar la perdida de proteinas a concentraciones de proteinas bajas.
BRPI0813619A2 (pt) peptídeos surfactantes pulmonares sintéticos
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
EP4218786A3 (en) Opiorphin for use as analgesic agent
DE602006020155D1 (de) Pharmazeutische wundheilungs-zusammensetzungen in ren und natriumhyaluronat
TW200732002A (en) Lens care compositions having a persistent cleaning efficacy
NZ741483A (en) Antibody and protein formulations
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2